About / Media Center
Trinity News
Filter by Type:
AI is Ushering in a New Era for Life Sciences, According to Top Life Sciences Firm
Trinity Life Sciences’ Head of Digital & AI Solutions, Jonathan Jenkins, spoke with Grit Daily about how artificial intelligence is transforming the life sciences industry by shifting it from static insights to dynamic, continuous intelligence.
Health equity can be a competitive advantage: What pharma leaders need to know
Trinity Life Sciences’ Managing Director and Head of Value Center of Excellence, Mary Fletcher-Louis, spoke with pharmaphorum about how health equity can be a competitive advantage in HTA decisions.
NICE leads global shift: How health equity is influencing drug approvals
Trinity Life Sciences’ Managing Director and Head of Value Center of Excellence, Mary Fletcher-Louis, spoke with Access Insider about how the UK’s National Institute for Health and Care Excellence (NICE) is spearheading a global shift in pharmaceutical decision-making by incorporating health...
Argenx’s Vyvgart tops Trinity’s latest launch success analysis, beating out several Big Pharma debuts
The Trinity Annual Drug Index was featured in an article by Fierce Pharma: Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, according to the latest edition of Trinity Life...
Changing Political Winds and the IRA: Q&A with Monica Martin de Bustamante
Trinity’s Monica Martin de Bustamante, Senior Partner & Head of Advisory, spoke with Pharmaceutical Executive about the Inflation Reduction Act and how companies are attempting to strategize around the uncertainty of upcoming pricing negotiations. Read the article to learn more.
Trinity Life Sciences Releases Annual TGaS Digital Marketing Competency Report
Check out Pharmaceutical Executive’s article entitled, “Trinity Life Sciences Releases Annual TGaS Digital Marketing Competency Report” to learn more about our annual TGaS Digital Marketing Competency Report:
Pfizer’s Nurtec, AstraZeneca’s Breztri top pharma brand report
Trinity’s Jerry Luciano and Tim McLaughlin were featured in an article by MM+M titled, “Pfizer’s Nurtec, AstraZeneca’s Breztri top pharma brand report.” The article focuses on the findings of the fourth annual TGaS Digital Marketing Competency Report. Read the article to...
2024 Digital Insights: Pfizer’s Nurtec and AstraZeneca’s Breztri Shine
Trinity Life Sciences’ fourth annual TGaS Digital Marketing Competency Report was featured in an article published on Investors Hangout.
How to achieve a successful drug launch in the first year
Trinity’s Krista Perry, Partner & Head of Launch Excellence, was featured in an article by MM+M titled, “How to achieve a successful drug launch.” Read the article to learn more about what factors contribute to a successful drug launch.
The Challenges and Opportunities in Clinical Trial Diversity: Mistrust in the healthcare system is a significant barrier to recruitment
Trinity’s Lisa Bailey, Ph.D., Managing Director of Insights & Head of DEI Strategy, authored an article that was published in Drug Discovery Today. Read the article, “The Challenges and Opportunities in Clinical Trial Diversity: Mistrust in the healthcare system is a...
Drugs for unmet needs and those from experienced companies had the best chance for successful launches in 2023: report
Trinity’s Krista Perry, Partner & Head of Launch Excellence, was featured in an article by Fierce Pharma to discuss our latest white paper, Moving the Needle: Lessons from the 2023 Launch Class. Read the article to learn more about what factors...
Half of US meds launched in 2023 ‘underperformed’
Trinity Life Sciences’ recent white paper on the first year performance of the 2023 launch class was featured in an article published on The Pharma Letter.